Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$7.78 - $8.62 $3,018 - $3,344
-388 Reduced 5.84%
6,253 $51,000
Q3 2023

Nov 09, 2023

SELL
$7.85 - $8.94 $6,460 - $7,357
-823 Reduced 11.03%
6,641 $55,000
Q2 2023

Aug 10, 2023

SELL
$8.04 - $9.0 $9,245 - $10,350
-1,150 Reduced 13.35%
7,464 $62,000
Q1 2023

May 12, 2023

SELL
$7.57 - $8.37 $10,219 - $11,299
-1,350 Reduced 13.55%
8,614 $70,000
Q4 2022

Feb 13, 2023

BUY
$5.96 - $8.06 $59,385 - $80,309
9,964 New
9,964 $79,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.8B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Delta Asset Management LLC Portfolio

Follow Delta Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Asset Management LLC with notifications on news.